This regimen was repeated once every 3 weeks. Treatment cycles continued for two cycles. Treatment Modalities. Patients proceeded to surgery during the 2–3 weeks after completion of the neoadjuvant chemotherapy. After laparotomy, the resectability was evaluated. The standard surgery for primary ...
This study compared the immunogenicity of an influenza vaccine administered concurrently with chemotherapy (day 1) and within the cytopenic period (day 11) during 3-week cytotoxic chemotherapy cycles.Cancer
You may have chemotherapy in “cycles” or “rounds.” This means a period of treatment and then a period of rest. For example, a 4-week cycle may mean 1 week of treatment and then 3 weeks of rest. The rest allows your body to make new healthy cells. Once a cycle has been planned...
every 3 weeks with chemotherapy. The chemotherapy agents used in the study include cisplatin 80 mg/m2via IV infusion on day 1, oral capecitabine 1000 mg/m2on days 1 to 14, or cisplatin 80 mg/m2via IV infusion on day with 5-fluorouracil on day 1. All...
All patients underwent two 3-week cycles of neoadjuvant therapy. The Cam+nab-TP group received camrelizumab (200 mg on day 1), albumin-bound paclitaxel (125 mg/m² on days 1 and 8), and cisplatin (75 mg/m² on day 1). The Cam+TP group was administered camrelizumab ...
Cancer symptoms improved between baseline and 9 weeks in all arms similarly (eFigures 8-12 in Supplement 3). The rate of toxic effects fell markedly with reducing dose levels (Table 2). Consequently, treatment delivery was more reliable: during the first three 3-week cycles, comparing Levels ...
We compared low-dose with high-dose CAF in study 8541, no paclitaxel with paclitaxel in study 9344, and 3-week with 2-week cycles in study 9741. We considered patients with ER-positive tumors only if they received tamoxifen. We used Kaplan-Meier methods to determine survival according to ...
b)Proton group:Synchronous Chemotherapy Regimen: Paclitaxel Albumin-bound 175 mg/m2 IV on Day 1 + Cisplatin 75 mg/m2 IV on Day 1, every 3 weeks, for 4–6 cycles. Clinical efficacy and toxicity assessment (1)Clinical efficacy assessment followed the RECIST v1.1 evaluation criteria [6],...
All patients received TPF (docetaxel 75 mg/m2, cisplatin 75 mg/m2, and 5-FU 2500 mg/m2 every 3 weeks for 3 cycles) followed by cisplatin 40 mg/m2 per week concurrently with either 3-dimentional conformal radiation therapy or intensity-modulated radiation therapy.RESULTSFrom January 2007 to ...
(200 mg, day 1), and platinum-based chemotherapy of each three-week cycle for 3 cycles, followed by surgery within 4–6 weeks. Adjuvant sintilimab (200 mg) was administered every 3 weeks. The primary endpoint was achieving a pathological complete response (pCR). From June 10, 2021 ...